DB
PFE icon

Danske Bank’s Pfizer PFE Stock Holding History

Danske Bank’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.6M Buy
3,677,679
+309,400
+9% +$8.09M 0.18% 102
2026
Q1 		$94.6M Sell
3,368,279
-51,672
-2% -$1.38M 0.23% 80
2025
Q4 		$85.2M Buy
3,419,951
+229,304
+7% +$5.78M 0.2% 94
2025
Q3 		$81.3M Sell
3,190,647
-1,045,478
-25% -$25.8M 0.2% 90
2025
Q2 		$103M Buy
4,236,125
+536,714
+15% +$12.5M 0.26% 69
2025
Q1 		$93.7M Buy
3,699,411
+495,368
+15% +$13M 0.29% 62
2024
Q4 		$85M Sell
3,204,043
-514,800
-14% -$14M 0.25% 66
2024
Q3 		$108M Buy
3,718,843
+944,413
+34% +$27.5M 0.36% 45
2024
Q2 		$77.6M Buy
2,774,430
+93,602
+3% +$2.58M 0.29% 58
2024
Q1 		$74.4M Buy
+2,680,828
New +$74.4M 0.23% 79

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Danske Bank's PFE Position: Q2 2026 in Review

Danske Bank increased its Pfizer (PFE) stake by 9.2% in Q2 2026, buying an estimated $8.09M and bringing the position to 3,677,679 shares worth $88.6M. The position accounts for 0.18% of the portfolio, ranked #102.

Danske Bank first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $108M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Danske Bank held 3,677,679 shares of Pfizer worth $88.6M as of Q2 2026.
  • Danske Bank bought 309,400 Pfizer shares in Q2 2026, an estimated $8.09M.
  • Pfizer made up 0.18% of Danske Bank's portfolio in Q2 2026, its #102 holding.
  • Danske Bank first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Pfizer position peaked at $108M in Q3 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.